Canine cancer screening via ultraviolet absorbance and fluorescence spectroscopy of serum proteins

Applied Optics

Volumn 46, Issue 33, 2007, Pages 8080-8088

  Dickerson, Bryan D ^a   Geist, Brian L ^b   Spillman Jr , William B ^b   Robertson, John L ^b  

^a LUNA INNOVATIONS INC   (United States)

^b VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORESCENCE SPECTROSCOPY; HEMOGLOBIN; PATIENT MONITORING; PHOTOLUMINESCENCE SPECTROSCOPY;

BLOOD CHEMISTRY ANALYSIS METHODS; CANINE CANCER SCREENING; SERUM PROTEINS; ULTRAVIOLET ABSORBANCE;

ONCOLOGY;

PLASMA PROTEIN; TUMOR MARKER; TUMOR PROTEIN;

ANIMAL; ARTICLE; BLOOD; BLOOD ANALYSIS; COMPUTER ASSISTED DIAGNOSIS; DOG; EVALUATION; METHODOLOGY; NEOPLASM; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SPECTROFLUOROMETRY; ULTRAVIOLET SPECTROPHOTOMETRY;

ANIMALS; BLOOD CHEMICAL ANALYSIS; BLOOD PROTEINS; DIAGNOSIS, COMPUTER-ASSISTED; DOGS; NEOPLASM PROTEINS; NEOPLASMS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, FLUORESCENCE; SPECTROPHOTOMETRY, ULTRAVIOLET; TUMOR MARKERS, BIOLOGICAL;

EID: 38849119049     PISSN: 1559128X     EISSN: 15394522     Source Type: Journal    
DOI: 10.1364/AO.46.008080     Document Type: Article

References (24)

1. R. S. Cotran, V. Kumar, and T. Collins, eds., Robbins Pathological Basis of Disease (Saunders, 1999), pp. 260-327.
2. R. Richards-Kortum, R. Drezek, K. Basen-Engquist, S. B. Cantor, U. Utzinger, C. Brookner, and M. Follen, "Cervical dysplasia diagnosis with fluorescence spectroscopy," in Handbook of Biomedical Fluorescence, M. A. Mycek and B. W. Poque, eds. (Marcel Dekker, 2003), pp. 265-314.
3. G. Wagnières, A. McWilliams, and S. Lam, "Lung cancer imaging with fluorescence endoscopy," in Handbook of Biomedical Fluorescence, M. A. Mycek and B. W. Poque, eds. (Marcel Dekker, 2003), pp. 361-396.
4. E. P. Diamandis, "How are we going to discover new cancer biomarkers? A proteomic approach for bladder cancer," Clin. Chem. 50, 793-795 (2004).
5. S. C. Gad, ed., Drug Discovery Handbook (Wiley-Interscience, 2005), pp. 81-83.
6. K. P. H. Pritzker, "Cancer biomarkers: Easier said than done," Clin. Chem. 48, 1147-1150 (2002).
7. R. Aebersold and M. Mann, "Mass spectroscopy-based proteomics," Nature (London) 422, 198-207 (2003).
8. J. Li, Z. Zhang, J. Rosenzweig, Y. Y. Wang, and D. W. Chan, "Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer," Clin. Chem. 48, 1296-1304 (2002).
9. A. Statnikov, C. Aliferis, I. Tsamardinos, D. Hardin, and S. Levy, "A comprehensive evaluation of multicategory classification methods for microarray gene expression cancer diagnosis," Bioinformatics 21, 631-643 (2005).
10. A. A. Pineda, ed., Selective Plasma Component Removal (Futura, 1984), p. 156.
11. B. F. Feldman, J. G. Zinkl, and N. C. Jain, eds., Schalm's Veterinary Hematology, 5th ed. (Lippincott Williams & Wilkins, 2000), pp. 565-570 and 899-903.
12. M. R. Hubmann, M. J. P. Leiner, and R. J. Schaur, "Ultraviolet fluorescence of human sera: I. Sources of characteristic differences in ultraviolet fluorescence spectra from sera of normal and cancer-bearing patients," Clin. Chem. 36, 1880-1883 (1990).
13. S. Welle, Human Protein Metabolism (Springer, 1999), pp. 204-204.
14. R. J. Henry, D. C. Cannon, and J. W. Winkelman, eds., Clinical Chemistry Principles and Techniques, 2nd ed. (Harper & Row, 1974), pp. 449, 1071-1072, 1117, and 1239.
15. M. Kondo, N. Hirota, T. Takaoka, and M. Kajiwara, "Heme biosynthetic enzyme activities and porphyrin accumulation in normal liver and hepatoma cell lines of rat," Cell. Biol. Toxins 9, 95-105 (1993).
16. R. Beri and R. Chandra, "Chemistry and biology of heme: effect of metal salts, organometals, and metalloproteins on heme synthesis and catabolism, with special reference to clinical implications and interactions with cytochrome P-450," Drug Metab. Rev. 25, 49-152 (1993).
17. B. R. Munson and R. J. Fiel, "A review: biochemical alterations associated with mouse spleen cells infected with Friend virus," J. Med. 4, 354-370 (1973).
18. T. S. Mang, C. McGinnis, C. Liebow, U. O. Nseyo, D. H. Cream, and T. J. Dougherty, "Fluorescence detection of tumors," Cancer 71, 269-276 (1993).
19. D. M. Harris and J. Werkhaven, "Endogenous porphyrin fluorescence in tumors," Lasers Surg. Med. 7, 467-472 (1987).
20. P. Jichlinski, M. Forrer, J. Mizeret, T. Glanzmann, D. Braichotte, G. Wagnières, G. Zimmer, L. Gulillou, F. Schmidlin, P. Graber, H. van den Bergh, and H. J. Leisinger, "Clinical evaluation of a method for detecting superficial transitional cell carcinoma of the bladder by light-induced fluorescence of protoporphyrin IX following topical application of 5-aminolevulinic acid," Lasers Surg. Med. 20, 402-408 (1997).
21. B. Leca-Bouvier and L. J. Blum, "Biosensors for protein detection: a review," Anal. Lett. 38, 1491-1517 (2005).
22. C. V. Sapan, R. L. Lundblad, and N. C. Price, "Colorimetric protein assay techniques," Biotechnol. Appl. Biochem. 29, 99-108 (1999).
23. M. Weiss, C. L. Loprinzi, E. T. Creagan, R. J. Dalton, P. Novotny, and J. R. O'Fallon, "Utility of follow-up tests for detecting recurrent disease in patients with malignant melanomas," J. Am. Med. Assoc. 274, 1703-1705 (1995).
24. L. Pena, M. D. Perez-Alenza, A. Rodriguez-Bertos, and A. Nieto, "Canine inflammatory mammary carcinoma: histopathology, immunohistochemistry and clinical implications of 21 cases," Breast Cancer Res. Treat. 78, 141-148 (2003).